STEP vs VRTX · rev $1.99B vs P/E 30, rev $12.00B
Stepstone Group Inc (STEP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
STEP currently screens at market cap $5.78B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the STEP and VRTX stock pages for the full models.
Not investment advice.